This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Pathway
HRD1/SEL1 ERAD complex, organism-specific biosystem; HRD1/SEL1 ERAD complex, conserved biosystem; Hypoxic and oxygen homeostasis regulation of HIF-1-alpha, organism-specific biosystem; Protein processing in endoplasmic reticulum, organism-specific biosystem; Protein processing in endoplasmic reticulum, conserved biosystem;
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited DCABH-12729 in a publication? Let us know and earn a reward for your research.
Kolb, EA; Kamara, D; et al. R1507, A Fully Human Monoclonal Antibody Targeting IGF-1R, Is Effective Alone and in Combination With Rapamycin in Inhibiting Growth of Osteosarcoma Xenografts. PEDIATRIC BLOOD & CANCER 55:67-75(2010).
RAHA, D; CARLSON, J; et al. OS9 - A NOVEL OLFACTORY GENE OF DROSOPHILA EXPRESSED IN 2 OLFACTORY ORGANS. JOURNAL OF NEUROBIOLOGY 25:169-184(1994).
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Anti-OS9 monoclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.